30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Personalized Stem Cells Enrolls in Clinical Trial for Treatment of OA with Stem Cells -

Personalized Stem Cells (PSC) enrolled the first patients in an FDA-approved clinical trial for treatment of knee osteoarthritis with stem cells. Trial sites are located throughout the U.S., with more to come in 4Q19 and early 2020. Future trials are planned for other orthopedic applications. PSC is working within FDA guidelines to provide alternatives to unregulated, in-clinic stem cell processing and unapproved regenerative therapies that have come under scrutiny by FDA, FTC and the Federation of State Medical Boards. (Personalized Stem Cells, 10/2/19)